Looking at the change of Ki-67 due to neoadjuvant treatment seems to be more dynamic and informative as discussed elsewhere [24], as it could also provide information about tumor sensitivity to chemotherapy and targeted therapy. The gene discussed is MKI67; the disease is neoplasm.